Neurology Inpatient Clinical Education Trial
CompletedNot applicableNCT03826056
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The objective of this study is to compare the effectiveness of a personalized patient education program to the current hospital education and evaluate its impact using patient satisfaction scores. The investigators hypothesize that a personalized patient education intervention will increase patient's understanding of their diagnosis and satisfaction with the care as reflected in the survey results.
Study details
- Official title
- Neurology Inpatient Clinical Education Trial
- Conditions
- Myasthenia Gravis
- Guillain-Barre Syndrome
- Multiple Sclerosis
- Seizures
- Parkinsonism
- Meningitis
- Encephalitis
- Headache
- Vestibular Disorder
- Spondylosis
- Normal Pressure Hydrocephalus
- Interventions
- Behavioral: Current standard discharge educational intervention
- Behavioral: Personalized discharge educational intervention
- Sponsor
- Dartmouth-Hitchcock Medical Center
- Start date
- 2019-02-01
- Primary completion
- 2021-12-07
- Sex
- All
- Age range
- from 18 Years to 95 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Over the age of 18 * Must have the capacity to consent and understand the study related activities and education materials. Exclusion Criteria: * Under the age of 18 * Have a condition that impairs the ability to understand the study, its risks, and appropriately consent for the study
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03826056